What is Leerink Partnrs’ Forecast for TNGX Q3 Earnings?
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Tango Therapeutics in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings of ($0.30) per share for the quarter. The […]
Tango Therapeutics, Inc. (NASDAQ:TNGX – Free Report) – Equities researchers at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for Tango Therapeutics in a note issued to investors on Wednesday, February 5th. Leerink Partnrs analyst A. Berens forecasts that the company will post earnings of ($0.30) per share for the quarter. The […]
